Case Control Study
Copyright ©The Author(s) 2021.
World J Clin Cases. Nov 16, 2021; 9(32): 9731-9740
Published online Nov 16, 2021. doi: 10.12998/wjcc.v9.i32.9731
Table 1 Clinical data of patients enrolled
Clinical data
n (%)
Gender
Male75 (60)
Female50 (40)
Age
Age distribution33-67
Average53 ± 11
Mechanical ventilation105 (84)
ARDS occurrence52 (42)
Improvement39 (31)
Death13 (10)
Average APACHE II score11 ± 5
Department type
General surgery77 (62)
Orthopedics25 (20)
Other23 (18)
Table 2 Comparison of the levels of circulating endothelial cells in three groups, mean ± SD
Group
Number
Count of CECs, in mL
ARDS Group522064 ± 892
Non-ARDS Group731038 ± 1371
Healthy control group32167 ± 148
Table 3 Comparison of day 2 circulating endothelial cells levels between death group and improvement group in acute respiratory distress syndrome patients, mean ± SD
Group
Number
Count of CECs, mL
P value
Deceased group132863 ± 651< 0.001
Improvement group391799 ± 801
Table 4 Comparison of number of day 2 circulating endothelial cells in patients with acute respiratory distress syndrome under different severity, mean ± SD
Severity of ARDS
Number
Count of CECs, mL
Mild191924 ± 872
Moderate201897 ± 890
Severe132580 ± 791
Table 5 Changes of circulating endothelial cells levels in three groups as acute respiratory distress syndrome development, mean ± SD
Group
Number
Count of CECs, mL
P value
Count of d2 CECs
Count of d5 CECs
Non-ARDS group731038 ± 1371854 ± 6480.273
Improvement group391799 ± 8012274 ± 1017< 0.001
Death group132863 ± 6523548 ± 10350.002